CXCR4 signaling identifies a role for IFT2 in ER-negative breast cancers.
Brody
Jonathan R
JR
Department of Surgery, Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. Jonathan.Brody@jefferson.edu
Witkiewicz
Agnieszka K
AK
D000818:Animals; D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / Q000235:genetics* / Q000378:metabolism; D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D045744:Cell Line, Tumor; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D051379:Mice; D009361:Neoplasm Invasiveness; D019718:Receptors, CXCR4 / Q000235:genetics* / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D015398:Signal Transduction; D000073940:Transcription Factor 4; D014157:Transcription Factors / Q000235:genetics* / Q000378:metabolism; D014183:Transplantation, Heterologous; D047368:Tumor Burden
D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; C527276:CXCR4 protein, human; D019718:Receptors, CXCR4; D011960:Receptors, Estrogen; C532096:TCF4 protein, human; D000073940:Transcription Factor 4; D014157:Transcription Factors